Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

GSK Partners with Vodafone for Vaccinations

December 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

GlaxoSmithKline has formed a partnership with Vodafone to use mobile technology to help vaccinate more children against common infectious diseases in Africa.

BASF Extends Offer Period to Acquire Pronova BioPharma

December 19, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

BASF extended its offer period to acquire Pronova BioPharma, a producer of omega-3 fatty acids.

Ranbaxy Issues Voluntary Recall of Atorvastatin Due to Quality Issues

December 4, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The company issues voluntary recall of certain lots due to possible contamination with small glass particles.

US Supreme Court to Hear Myriad Genetics' Gene Patentability Case

December 4, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Myriad Genetics reports that the US Supreme Court has granted certiorari agreeing to hear the company's gene patentability case.

EMA Publishes Plan to Deal with Supply Shortages

December 3, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency has published a plan to help Europe?s regulatory network prevent, mitigate and manage shortages of important medicines following manufacturing problems.

Development and Commercialization of a Novel Modified Release Tablet Technology

December 2, 2012

Pharmaceutical Technology

GlaxoSmithKline recently developed a novel technology for the formulation of modified-release tablets. The authors describe the route from development to commercialization.

Pharma Innovation

December 2, 2012

Pharmaceutical Technology

A look at the year's leaders in innovation strategy, including the top bio/pharmaceutical companies and award recipients from AAPS, PhRMA, and CPhI.

Europe Considers Black Box Warnings

November 26, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Commission (EC) is seeking to introduce a black symbol to identify medicines that are subject to additional monitoring.

First Seasonal Influenza Vaccine Produced in Cell Culture Approved in US

November 26, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novartis announced that it has received FDA approval for a seasonal influenza vaccine produced in cell culture, the first seasonal vaccine produced by this method to be approved in the US.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here